Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

CHU De Rouen

Verified siteinfo

France 147 Avenue Du Marechal Juin, 76230 Bois-Guillaume, France

  • 2 trials recruiting
  • Anti-glomerular basement membrane disease · Hidradenitis · Renal transplant
  • Adult patients

About Specializations

CHU De Rouen in Bois-Guillaume, France specialises in clinical trials of conditions such as Anti-glomerular basement membrane disease, Hidradenitis, Renal transplant, and other specialisations. This site conducts important research.

Main research areas of the site

Transplant Immunology

The medical center is at the forefront of transplant immunology, focusing on innovative approaches to improve outcomes for kidney transplant recipients. The center's research is dedicated to enhancing the understanding of immune responses in sensitized patients, particularly those without pre-existing donor-specific antibodies.

  • Acute Rejection Prevention
  • Immunosuppressive Therapies
  • Biopsy-Proven Acute Rejection (BPAR) Studies

Through its pioneering work, the center contributes significantly to the development of more effective immunosuppressive strategies, such as the comparison of rATG and basiliximab, to prevent acute rejection in kidney transplant recipients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
147 Avenue Du Marechal Juin76230 Bois-GuillaumeFrance
Open in maps ↗
Recruiting now
2 trials
Conditions studied
3
Partner status
Verified site

More sites in Bois-GuillaumeFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

3 clinical trials

Renal transplant

Recruiting

Study on Preventing Rejection in Kidney Transplant Patients Using Rabbit Anti-Human Thymocyte Immunoglobulin and Basiliximab

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Basiliximab
  • Sponsor:Centre Hospitalier Regional Universitaire De Tours

Hidradenitis

Recruiting

Study on the Effectiveness of Ceftriaxone and Metronidazole Combination for Patients with Hurley Stage 2 Hidradenitis Suppurativa

Registered drug
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Ceftriaxone
  • Sponsor:Institut Pasteur

Anti-glomerular basement membrane disease

Not recruiting

Study on Imlifidase and Drug Combination for Treating Severe Goodpasture Disease in Patients

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Hansa Biopharma AB
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.